Table 2.
The efficacy of Tfh subsets in distinguishing active UC from stable remission UC patients
| AUC | Cut‐off value (%) | Sensitivity | Specificity | |
|---|---|---|---|---|
| ICOS+PD‐1+ Tfh | 0·883 | 2·48 | 81·9 | 89·1 |
| ICOS+ Tfh | 0·722 | 3·43 | 71·3 | 62·9 |
| PD‐1+ Tfh | 0·728 | 11·8 | 81·2 | 59·2 |
| ICOS+PD‐1+ Tfh plus PD‐1+ Tfh | 0·931 | 2·53 + 11·4 | 86·3 | 89·1 |
| ICOS+PD‐1+ Tfh plus ICOS+ Tfh | 0·826 | 2·60 + 3·38 | 81·7 | 84·2 |
| ICOS+ Tfh plus PD‐1+ Tfh | 0·832 | 3·51 + 11·8 | 82·9 | 83·8 |
AUC = area under the receiver operating characteristic (ROC) curve; ICOS = inducible co‐stimulator; PD‐1 = programmed cell death protein 1; Tfh = follicular helper T cells; UC = ulcerative colitis.